21 CFR 803.33 User Facility Reporting
Understand 21 CFR 803.33 with expert support for user facility MDR obligations, annual reporting, event evaluation, and documentation controls. Elexes helps medical device organizations build defensible reporting workflows, reduce missed deadlines, and align complaint handling, post-market surveillance, and FDA reporting expectations with practical regulatory execution.
Our User Facility Reporting Services
Targeted regulatory support for MDR assessments, reporting workflows, audits, training, and ongoing post-market compliance oversight.
Reportability Support
Assess adverse events, malfunctions, and complaint records against FDA MDR criteria to determine whether reporting is required and document the rationale clearly.
Complaint Governance
Strengthen complaint intake, investigation, escalation, and closure processes so potential MDR events are identified promptly and handled with defensible documentation.
Internal Audits
Review complaint handling, post-market surveillance, and reporting controls to identify compliance gaps before an FDA inspection or external audit.
Compliance Training
Train internal teams on user facility reporting obligations, event triage, documentation standards, and escalation pathways under applicable FDA requirements.
Regulatory Outsourcing
Extend your internal RAQA capacity with embedded experts who can support ongoing reporting decisions, documentation reviews, and regulatory follow-through.
Agency Response
Prepare structured responses to FDA inquiries, inspection observations, or follow-up questions related to MDR reporting and post-market compliance activities.
Our MDR Support Process
Review Event Intake and Records
We examine complaint files, incident details, device history, and existing procedures to understand how potential reportable events are currently identified, documented, and escalated within your organization.
Assess Reportability Criteria
Our consultants evaluate each event against applicable FDA MDR requirements, including user facility obligations under 21 CFR Part 803, and document a clear, defensible reporting determination.
Close Gaps in Procedures
We identify weaknesses in complaint handling, investigation quality, timelines, annual reporting controls, and decision records, then recommend practical remediation steps aligned with your quality system.
Support Submission and Follow-Up
When reporting is required, we help prepare accurate submissions, supporting narratives, and internal records so your team can meet deadlines and respond confidently to regulatory scrutiny.
Trusted Regulatory Support
Compliance Outcomes
Helping medical device organizations improve reporting accuracy, audit readiness, and post-market compliance performance.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Elexes brings deep medical device regulatory and quality expertise to complex reporting and post-market obligations.
Deep Expertise
50+ years of collective experience across FDA, ISO 13485, EU MDR, and global frameworks.
End-to-End Support
From event assessment to post-market governance, Elexes supports the full compliance lifecycle.
Audit Readiness
A 90% audit clearance rate reflects disciplined documentation, review rigor, and inspection-focused execution.
Flexible Delivery
Project-based, part-time, or embedded RAQA support helps teams scale without adding permanent headcount.
Meet The Elexes Team
Experienced regulatory specialists supporting complex medical device compliance.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device companies navigate demanding regulatory pathways with clarity and discipline. The team supports organizations across FDA, EU, TGA, Health Canada, and other frameworks, with particular strength in regulatory due diligence, quality systems, submissions, and post-market obligations. For reporting-intensive requirements such as 21 CFR Part 803, Elexes combines regulatory judgment with operational execution so clients can make timely, defensible decisions. With 50+ years of collective experience, 250+ successful projects, and support across 200+ product types, Elexes serves as a practical extension of internal RAQA teams for startups, scaling manufacturers, and established global device companies.
50+ YearsCollective regulatory and quality experience250+ ProjectsSuccessful engagements across device lifecycles90% Audit ClearanceStrong inspection and audit readiness outcomes
Frequently Asked Questions
What is the FDA regulation 21 CFR 803?
21 CFR Part 803 is the FDA’s Medical Device Reporting regulation. It establishes when manufacturers, importers, and user facilities must report certain device-related adverse events and malfunctions. The rule covers reportability criteria, submission timelines, recordkeeping, and annual reporting obligations. Its purpose is to help FDA monitor device safety issues after products are in use and identify trends that may require corrective action.
What does 21 CFR 803.33 specifically require from user facilities?
21 CFR 803.33 addresses annual reporting by user facilities. User facilities must submit annual summaries of reportable events to FDA on the required schedule and maintain records supporting those submissions. This requirement works alongside immediate reporting obligations for deaths and serious injuries. Strong internal controls are essential so complaint files, event evaluations, and prior submissions are accurately captured and reflected in the annual report.
Who qualifies as a user facility under FDA MDR rules?
A user facility generally includes hospitals, ambulatory surgical facilities, nursing homes, outpatient diagnostic facilities, and treatment centers that use medical devices in patient care. Physician offices are typically excluded unless they meet specific criteria under the regulation. Because classification affects reporting obligations, organizations should confirm whether their facility type falls within FDA’s MDR definition before building procedures or making reportability decisions.
When must a user facility report a device-related death or serious injury?
User facilities must report device-related deaths to both FDA and the manufacturer, and serious injuries to the manufacturer or to FDA if the manufacturer is unknown. These reports are generally due within 10 work days after becoming aware of information that reasonably suggests a reportable event occurred. Timely intake, escalation, and documented decision-making are critical to meeting the deadline consistently.
What records should a user facility maintain for MDR compliance?
Organizations should maintain complaint and incident records, event investigation files, reportability assessments, copies of submitted MDRs or annual reports, correspondence, and supporting evidence used to reach reporting decisions. Records should show dates of awareness, escalation steps, conclusions, and submission timing. A complete audit trail helps demonstrate that the facility evaluated events consistently and met both reporting and recordkeeping obligations under Part 803.
How can a user facility determine whether an adverse event is reportable?
A reportability assessment should review the event facts, device involvement, patient outcome, available clinical information, and whether the incident meets the definitions of death, serious injury, or other reportable criteria under FDA MDR rules. The decision should be documented with a clear rationale, not just a conclusion. Standardized triage procedures, trained reviewers, and quality oversight reduce inconsistent judgments and missed reporting obligations.
What services does Elexes offer to support 21 CFR 803.33 compliance?
Elexes offers a range of user facility reporting services, including reportability assessments, complaint governance support, internal audits, compliance training, regulatory outsourcing, and agency response preparation. These services cover the full compliance lifecycle — from event assessment and complaint intake to post-market governance — helping organizations build defensible reporting workflows and reduce missed deadlines.
How can regulatory consultants help a user facility achieve 21 CFR 803.33 compliance?
Regulatory consultants can review procedures, assess complaint and incident workflows, evaluate reportability decisions, support annual reporting preparation, and identify documentation gaps before inspections or audits. They also help align complaint handling, post-market surveillance, CAPA, and risk management interfaces so reporting decisions are made consistently. This is especially valuable for organizations with limited internal RAQA bandwidth or complex post-market compliance responsibilities.
Need Help Interpreting MDR Requirements?
Speak with regulatory experts about reportability, records, and annual reporting controls.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance capability
